Zobrazeno 1 - 10
of 204
pro vyhledávání: '"Michiko Yamada"'
Autor:
Yohei Arihara, Ryo Shibuya, Michihiro Ono, Norito Suzuki, Ginji Omori, Yuki Ikeda, Hajime Nakamura, Michiko Yamada, Tomoyuki Abe, Kohichi Takada, Masahiro Maeda
Publikováno v:
Palliative Medicine Reports, Vol 4, Iss 1, Pp 334-338 (2023)
Background: Due to the lack of studies, the long-term prognoses of unfit patients with gastric cancer (GC) who did not receive any aggressive cancer treatment (best supportive care [BSC] cases) remain unclear, especially for those with potentially cu
Externí odkaz:
https://doaj.org/article/197f41ccd43a4cd08708064642c88dd2
Autor:
Nobuharu Tamaki, Mayu Higuchi, Taisei Keitoku, Yudai Yamazaki, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada, Risa Okada, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Tatsuya Kanto, Masayuki Kurosaki, Namiki Izumi
Publikováno v:
JGH Open, Vol 8, Iss 4, Pp n/a-n/a (2024)
Abstract Background and Aim Magnetic resonance elastography (MRE) is used for the evaluation of liver fibrosis; however, it remains unclear whether MRE‐based liver stiffness is associated with hepatocellular carcinoma (HCC) development, particularl
Externí odkaz:
https://doaj.org/article/00b6fa8436ce46a8989df0a08634e2b5
Autor:
Michihiro Ono, Yuki Ikeda, Ginji Ohmori, Yohei Arihara, Ryo Shibuya, Atsushi Uesugi, Shutaro Oiwa, Ryo Ito, Makoto Usami, Michiko Yamada, Tomoyuki Abe, Masahiro Maeda
Publikováno v:
DEN Open, Vol 4, Iss 1, Pp n/a-n/a (2024)
Abstract Endoscopic ultrasound‐guided gallbladder drainage for patients with cholecystitis and high surgical risk is commonly performed by dilating the fistula before inserting the delivery sheath; however, this carries an increased risk of periton
Externí odkaz:
https://doaj.org/article/037a92fc7321423eaa56d71968b6a9a4
Autor:
Shun Ishido, Nobuharu Tamaki, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada, Hiroaki Matsumoto, Tsubasa Nobusawa, Taisei Keitoku, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Masayuki Kurosaki, Namiki Izumi
Publikováno v:
JGH Open, Vol 7, Iss 8, Pp 567-571 (2023)
Abstract Background and Aim Hepatocellular carcinoma development can be decreased by achieving and maintaining complete virological response (CVR) in chronic hepatitis B. However, it is unclear whether switching from entecavir (ETV) to tenofovir alaf
Externí odkaz:
https://doaj.org/article/2a2f83f241f647a78232eee83eec28f4
Autor:
Shun Ishido, Nobuharu Tamaki, Yuka Takahashi, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada, Hiroaki Matsumoto, Tsubasa Nobusawa, Taisei Keitoku, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Masayuki Kurosaki, Namiki Izumi
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Patients with nonalcoholic fatty liver disease (NAFLD) are highly at risk for cardiovascular disease (CVD). However, the risk of developing CVD in patients with lean NAFLD is not yet fully understood. Therefore, this study aimed t
Externí odkaz:
https://doaj.org/article/196387580c6b4457bdf5411a8fa1646d
Autor:
Shun Ishido, Nobuharu Tamaki, Kento Inada, Jun Itakura, Yuka Takahashi, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada, Hiroaki Matsumoto, Tsubasa Nobusawa, Taisei Keitoku, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Masayuki Kurosaki, Namiki Izumi
Publikováno v:
Clinical Case Reports, Vol 11, Iss 7, Pp n/a-n/a (2023)
Key Clinical Message The liquid CGP was useful for detecting FGFR2 fusion and the patient experienced typical side effects (nail disorders, hyperphosphatemia, and taste disorders) of pemigatinib that required treatment.
Externí odkaz:
https://doaj.org/article/858567e6ea0540f5ab70e1b775051c30
Autor:
Yuki Ikeda, Michihiro Ono, Ginji Ohmori, Saki Ameda, Michiko Yamada, Tomoyuki Abe, Shigeyuki Fujii, Miri Fujita, Masahiro Maeda
Publikováno v:
Clinical Case Reports, Vol 9, Iss 4, Pp 2259-2263 (2021)
Key Clinical Message The tumor reduction effect of pembrolizumab is extremely high compared to standard chemotherapy and might show prolonged survival. Therefore, the MSI status should be examined in patients with cholangiocarcinoma.
Externí odkaz:
https://doaj.org/article/d69e052a852f435eb763717038fb06bd
Autor:
Shun Ishido, Kaoru Tsuchiya, Yoshihito Kano, Yutaka Yasui, Kenta Takaura, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada, Hiroaki Matsumoto, Tsubasa Nobusawa, Taisei Keitoku, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Yuka Takahashi, Hiroyuki Nakanishi, Urara Sakurai, Yasuhiro Asahina, Ryuichi Okamoto, Masayuki Kurosaki, Namiki Izumi
Publikováno v:
Cancers, Vol 15, Iss 3, p 719 (2023)
This study aimed to investigate the clinical usefulness of comprehensive genomic profiling (CGP) in patients with unresectable hepatocellular carcinoma who received multiple systemic therapies in real-world practice. In this study, all nine patients
Externí odkaz:
https://doaj.org/article/d274a0e521f449839a5921e1e7940e23
Autor:
Yukiko Imai, Sachiko Mizuno Tanaka, Michihiro Satoh, Takumi Hirata, Yoshitaka Murakami, Katsuyuki Miura, Takashi Waki, Aya Hirata, Toshimi Sairenchi, Fujiko Irie, Mizuki Sata, Toshiharu Ninomiya, Takayoshi Ohkubo, Shizukiyo Ishikawa, Yoshihiro Miyamoto, Hirofumi Ohnishi, Shigeyuki Saitoh, Akiko Tamakoshi, Michiko Yamada, Masahiko Kiyama, Hiroyasu Iso, Kiyomi Sakata, Hideaki Nakagawa, Akira Okayama, Hirotsugu Ueshima, Tomonori Okamura
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 23 (2021)
Background Lifetime risk is an informative estimate for driving lifestyle and behavioral changes especially for young adults. The impact of composite risk factors for cardiovascular disease on lifetime risk stratified by sex has not been investigated
Externí odkaz:
https://doaj.org/article/13db578ba3424ad48e594340d728c11c
Autor:
Hiroyasu Iso, Renzhe Cui, Iseki Takamoto, Masahiko Kiyama, Isao Saito, Tomonori Okamura, Yoshihiro Miyamoto, Aya Higashiyama, Yutaka Kiyohara, Toshiharu Ninomiya, Michiko Yamada, Hideaki Nakagawa, Masaru Sakurai, Michio Shimabukuro, Moritake Higa, Kazuaki Shimamoto, Shigeyuki Saito, Makoto Daimon, Takamasa Kayama, Mitsuhiko Noda, Sadayoshi Ito, Koutaro Yokote, Chikako Ito, Kazuwa Nakao, Toshimasa Yamauchi, Takashi Kadowaki
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 23 (2021)
Background It is uncertain whether risk classification under the nationwide program on screening and lifestyle modification for metabolic syndrome captures well high‐risk individuals who could benefit from lifestyle interventions. We examined the v
Externí odkaz:
https://doaj.org/article/1072e28ce9a34ac28fe7c82d7a2ebd72